ASCO Group Meetings

Join Us At ASCO 2025

May 31 to June 2, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into ASCO 2025 updates.

    Saturday, May 31
    9:00 AM CT (10:00 AM ET) - Neil Vasan
    • Breast Cancer | Physician-Scientist and an Assistant Professor of Medicine, Columbia University Medical Center
    9:00 AM CT (10:00 AM ET) - Michael Morse
    • PDAC/KRAS/CRC | Attending Physician, Duke University Health System Inc.
    10:00 AM CT (11:00 AM ET) - Rajwanth Veluswamy
    • NSCLC: Targeted | Medical Oncologist and Assistant Professor of Medicine, Hematology and Medical Oncology, The Mount Sinai Hospital
    10:00 AM CT (11:00 AM ET) - Rodabe Amaria
    • Melanoma, TILs | Associate Professor, Department of Melanoma Oncology, The University of Texas M. D. Anderson Cancer Center
    11:00 AM CT (12:00 PM ET) - David Sallman
    • AML/MDS | Associate Member, H. Lee Moffitt Cancer Center and Research Institute Hospital
    11:00 AM CT (12:00 PM ET) - Sanjay Aneja // VIRTUAL ONLY
    • GU: Prostate, radiopharma | Director of GU Oncology, Griffin Hospital Inc.
    12:00 PM CT (1:00 PM ET) - Jose Rauh-Hain // VIRTUAL ONLY
    • Ovarian/Gyn | Associate Professor of Gynecologic Oncology and Reproductive Medicine in Surgery and an Associate Professor of Health Services Research in OVP, Cancer Prevention, and Population Sciences, The University of Texas M. D. Anderson Cancer Center
    12:00 PM CT (1:00 PM ET) - Benjamin Besse
    • NSCLC: Targeted | Professor, University of Paris-Saclay
    1:00 PM CT (2:00 PM ET) - Seth Wander
    • Breast Cancer | Assistant Professor, Harvard Medical School
    2:00 PM CT (3:00 PM ET) - Elias Jabbour
    • AML/MDS, CML, ALL | Associate Professor, The University of Texas M. D. Anderson Cancer Center
    2:00 PM CT (3:00 PM ET) - Michael Pishvaian
    • PDAC/KRAS/CRC | Associate Professor, Johns Hopkins School of Medicine
    3:00 PM CT (4:00 PM ET) - Jason Henry
    • DDR/PRMT5/MAT2A | Assistant Director Drug Development Program, Sarah Cannon Research Institute LLC
    3:00 PM CT (4:00 PM ET) - Robert Dreicer
    • GU Cancer | Director of Solid Tumor Oncology within the Division of Hematology / Oncology, University of Virginia School of Medicine
    4:00 PM CT (5:00 PM ET) - Vamsidhar Velcheti
    • Lung | Co-Director, Cancer Biology Program, NYU Langone Hospitals
    Sunday, June 1
    9:00 AM CT (10:00 AM ET) - Jason Luke
    • Developmental IO | Associate Professor, University of Pittsburgh School of Medicine
    9:00 AM CT (10:00 AM ET) - Ran Reshef
    • CAR-Ts | Professor of Medicine at Columbia University Medical Center
    10:00 AM CT (11:00 AM ET) - Tanguy Seiwert
    • Head and Neck | Director of the Head and Neck Oncology Disease Group, the Co-Director of the Bloomberg-Kimmel Institute for Immunotherapy, and an Assistant Professor of Hematology/Oncology, Johns Hopkins University
    10:00 AM CT (11:00 AM ET) - Ryan Corcoran
    • PDAC/KRAS/CRC | Co-founder and Board of Directors Member at Alterome Therapeutics Inc.
    11:00 AM CT (12:00 PM ET) - Komal Jhaveri
    • Breast Cancer | Medical Oncologist and Clinical Director, Memorial Sloan Kettering Cancer Center
    11:00 AM CT (12:00 PM ET) - Eric Jonasch
    • RCC | Co-Director of the Kidney Cancer Research Program, Professor of Genitourinary Medical Oncology in the Division of Cancer Medicine, and Director of the VHL Clinical Center, The University of Texas M. D. Anderson Cancer Center
    12:00 PM CT (1:00 PM ET) - Joshua Brody
    • Lymphomas | Associate Professor, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai
    12:00 PM CT (1:00 PM ET) - Joshua Sabari
    • NSCLC: IO/targeted | Medical Oncologist and Assistant Professor of Medical Oncology, Perlmutter Cancer Center, NYU Langone Health System
    1:00 PM CT (2:00 PM ET) - Sandy Srinivas
    • Prostate Cancer and RCC | Oncologist, Stanford University
    1:00 PM CT (2:00 PM ET) - Brian Mulherin
    • Multiple Myeloma, Leukemia, Lymphoma, MPN | Oncologist and Managing Director, Hematology Oncology of Indiana (Community Based Medical Oncology and Hematology Practice)
    2:00 PM CT (3:00 PM ET) - Aarti Bhatia
    • Head and Neck Cancer | Clinical Research Team Leader for the Head and Neck Cancers Program and Associate Professor of Medical Oncology, Yale University School Of Medicine
    2:00 PM CT (3:00 PM ET) - Piro Lito
    • NSCLC: KRAS/RAS | Member, Memorial Sloan Kettering Cancer Center
    3:00 PM CT (4:00 PM ET) - Benjamin Herzberg
    • DDR/PRMT5/MAT2A/NSCLC | Medical Oncologist and Assistant Professor of Medicine, Columbia University Medical Center
    3:00 PM CT (4:00 PM ET) - Scott Tagawa
    • GU: Prostate | Attending Physician, The New York and Presbyterian Hospital Inc.
    4:00 PM CT (5:00 PM ET) - Thomas Marron
    • Developmental IO/NSCLC | Professor of Medicine, Hematology and Oncology, Icahn School of Medicine at Mount Sinai
    Monday, June 2
    9:00 AM CT (10:00 AM ET) - Ravi Vij
    • Multiple Myeloma | Founder, MyCancerHaven
    9:00 AM CT (10:00 AM ET) - Nataliya Uboha
    • PDAC/KRAS/CRC | Associate Professor, GI Medical Oncologist, University of Wisconsin - Madison
    10:00 AM CT (11:00 AM ET) - Konstantin Dragnev
    • NSCLC: IO/Targeted | Associate Director for Clinical Research, Dartmouth Cancer Center
    10:00 AM CT (11:00 AM ET) - Joshua Zeidner // VIRTUAL ONLY
    • AML/ MDS/ CML | Chief of Leukemia Research & Associate Chief of Hematology Research, University Of North Carolina At Chapel Hill
    11:00 AM CT (12:00 PM ET) - Ashwin Kishtagari
    • MPN (Myelofibrosis, PV, ET), AML/MDS, SM | Assistant Professor of Medicine, Vanderbilt University Medical Center
    11:00 AM CT (12:00 PM ET) - Jerome Fayette
    • Head and Neck Cancer | Medical Oncologist, Centre Léon Bérard
    12:00 PM CT (1:00 PM ET) - Patrick Forde
    • NSCLC: IO/Targeted | Professor/Chair of Immuno-Oncology, Trinity College Dublin, The University of Dublin
    12:00 PM CT (1:00 PM ET) - Giancarlo Moscol
    • Breast Cancer | Associate Professor in the Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center
    1:00 PM CT (2:00 PM ET) - Igor Puzanov
    • Melanoma TILs | Judith and Stanford Lipsey Chair in Clinical Cancer Research, Roswell Park Cancer Institute
    1:00 PM CT (2:00 PM ET) - Premal Thaker
    • Ovarian/Gyn | Associate Professor in Gynecologic Oncology and Director of Gynecological Oncology Clinical Research, Washington University, St. Louis
    2:00 PM CT (3:00 PM ET) - Thach-Giao Truong
    • Melanoma TILs | Hematologist and Medical Oncologist, Melanoma Program Medical Director, The Cleveland Clinic Foundation
    2:00 PM CT (3:00 PM ET) - Timothy Yap
    • DDR | Medical Director / Professor, The University of Texas M. D. Anderson Cancer Center
    3:00 PM CT (4:00 PM ET) - Jared Weiss
    • NSCLC: IO/Targeted | Professor of Medicine and Section Chief of Thoracic and Head & Neck Oncology at University of North Carolina at Chapel Hill School of Medicine
    3:00 PM CT (4:00 PM ET) - Victoria Wang
    • Lung | Oncologist/Assistant Professor, The University of California, San Francisco
    4:00 PM CT (5:00 PM ET) - Andrew Branagan // VIRTUAL ONLY
    • Multiple Myeloma | Clinical Investigator and Medical Director, Massachusetts General Hospital
    4:15 PM CT (5:15 PM ET) - Gautam Jayram // VIRTUAL ONLY
    • GU Bladder | Director, Urology Associates PC

    *ASCO Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.